CIC
BVS icon

Cornercap Investment Counsel’s Bioventus BVS Stock Holding History

Cornercap Investment Counsel’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-32,191
Closed -$338K – 198
2024
Q4 		$338K Hold
32,191
– – 0.11% 325
2024
Q3 		$385K Buy
+32,191
New +$278K 0.11% 309
2021
Q4 		– Sell
-69,133
Closed -$979K – 543
2021
Q3 		$979K Buy
69,133
+34,678
+101% +$534K 0.11% 346
2021
Q2 		$606K Buy
+34,455
New +$555K 0.07% 426

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Cornercap Investment Counsel's BVS Position: Q1 2025 in Review

Cornercap Investment Counsel sold out of Bioventus (BVS) in Q1 2025, closing a stake of 32,191 shares — an estimated $338K sold.

Cornercap Investment Counsel first reported a position in BVS in Q2 2021 and held it in 4 quarters. The position peaked at $979K in Q3 2021. 144 funds tracked by Wall St. Rank hold BVS as of Q1 2025.

  • Cornercap Investment Counsel reported no remaining Bioventus position as of Q1 2025 after selling out during the quarter.
  • Cornercap Investment Counsel sold 32,191 Bioventus shares in Q1 2025, an estimated $338K.
  • Cornercap Investment Counsel first reported a position in Bioventus in Q2 2021 and held it in 4 quarters.
  • Cornercap Investment Counsel's Bioventus position peaked at $979K in Q3 2021.
  • 144 funds tracked by Wall St. Rank held Bioventus as of Q1 2025.

Based on Cornercap Investment Counsel's 13F filing for Q1 2025, filed 2 May 2025.